Skip to content

Filter Results

Collection
Topic
The Distributed Partnering Model for Drug Discovery and Development

The major contributors to therapeutic innovations in the 20th century have been the pharmaceutical companies, with biotechnology companies adding significantly over the last twenty-five years. However, these models increasingly have failed in translating the advances of biomedical sciences into innovative products.

Characteristics of New Firms: A Comparison by Gender

This report indicates that women-owned firms have relatively underperformed men-owned firms in a number of measures. The Kauffman Foundation research tracked new businesses’ performance measures from 2004 to 2006 and correlated the data to gender based on primary owner characteristics, firm characteristics, industry and outcomes. It is third in a series of Kauffman Firm Survey (KFS) studies.

Sources of Financing for New Technology Firms: A Comparison by Gender

Credit card debt often fills startup firms’ equity gap, but those with continuing high balances have reduced likelihood of success, according to this report.

The Anatomy of an Entrepreneur series

Although entrepreneurs provide the majority of jobs in the United States, little is known about what makes them tick. The Anatomy of an Entrepreneur fills in some gaps by providing insights into high-growth founders’ motivations, their socio-economic, educational, and familial backgrounds, as well as their views on the factors determining the success of start-ups. 

The Coming Entrepreneurship Boom

This research indicated the United States might be on the cusp of an entrepreneurship boom—not in spite of an aging population but because of it.

Right Sizing the U.S. Venture Capital Industry

This short paper considers one aspect of the future of the venture capital industry, its size. How big should it be in terms of the aggregate underlying financial commitment to venture partnerships? Does it need to be larger to better equip entrepreneurs to solve the important problems we as a society face? Should it be smaller to take more risks, drive higher returns, and thus keep investors satisfied? How should we think about the role of venture capital in the future?